ISRG

Intuitive Surgical
D

ISRG

Arincen88/100B

Intuitive Surgical financials

Yes. Intuitive Surgical earned 2.96B USD of net income over the last twelve months, 25.5% of its revenue. It made a profit in 22 of its 28 fiscal years since 1998. Its last loss was in fiscal year 2003.

Revenue (TTM)
11.58B USD
Net income (TTM)
2.96B USD
Free cash flow (TTM)
3.60B USD
Cash and short-term investments
4.04B USD
Total debt
0.00 USD
Shareholders' equity
15.99B USD

Cash, debt and equity as of 30 Sept 2026.

Intuitive Surgical earnings

Next earnings · Q4 FY2026
EPS estimate
2.96 USD
Revenue estimate
3.24B USD
Last quarter · Q3 FY2026
EPS3.00Beat +13.2%Revenue3.05BBeat +4.9%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20273.19——+6.44%3.37B——+10.39%
Q2 FY20273.08——+10.15%3.25B——+12.35%
Q1 FY20272.86——+1.97%3.12B——+12.74%
Q4 FY20262.96——+17.00%3.24B——+12.96%
Q3 FY20262.653.00+13.21%+25.00%2.91B3.05B+4.88%+21.70%
Q2 FY20262.512.80+11.55%+27.85%2.83B2.89B+2.37%+18.54%
Q1 FY20262.512.80+11.55%+54.70%2.62B2.77B+5.81%+22.96%
Q4 FY20252.272.53+11.45%+14.48%2.76B2.87B+3.75%+18.76%
Q3 FY20251.992.40+20.60%+30.43%2.41B2.51B+4.10%+22.91%
Q2 FY20251.932.19+13.47%+23.03%2.35B2.44B+3.77%+21.40%

Intuitive Surgical growth and profitability

Full income statement
Revenue (TTM)
11.58B USD
Net income (TTM)
2.96B USD
Gross margin
67.19%
Operating margin
28.37%
Net margin
25.54%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202510.06B+20.51%2.86B+22.97%66.00%29.27%28.38%3.99B+27.19%
FY20248.35B+17.24%2.32B+29.18%67.46%28.12%27.81%3.14B+29.92%
FY20237.12B+14.49%1.80B+35.98%66.39%24.80%25.24%2.41B+22.36%
FY20226.22B+8.97%1.32B-22.43%67.44%25.35%21.25%1.97B-10.36%
FY20215.71B+31.01%1.70B+60.72%69.32%31.89%29.85%2.20B+65.95%

How Intuitive Surgical makes its money

Instruments and Accessories6.02B 59.8%
Systems2.47B 24.6%
Services1.57B 15.6%
Revenue10.06B 100.0%
Cost of revenue3.42B 34.0%
Gross profit6.64B 66.0%
Research and development1.31B 13.0%
Selling and administration2.39B 23.7%
Operating income2.95B 29.3%
Tax434.80M 4.3%
Net income2.86B 28.4%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Intuitive Surgical revenue breakdown

By product

FY2025
Instruments and Accessories: 59.8%Systems: 24.6%Services: 15.6%59.8%Instruments and Accessories24.6%Systems15.6%Services
SegmentRevenueShare of revenueChange on the year
Instruments and Accessories6.02B59.8%+18.5%
Systems2.47B24.6%+25.8%
Services1.57B15.6%+20.3%

By region

FY2025
Geographic Distribution, Domestic: 67.7%Geographic Distribution, Foreign: 32.3%67.7%Geographic Distribution, Domestic32.3%Geographic Distribution, Foreign
RegionRevenueShare of revenueChange on the year
Geographic Distribution, Domestic6.82B67.7%—
Geographic Distribution, Foreign3.25B32.3%—

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20253.03B2.49B
FY20242.42B1.30B
FY20231.81B749.60M
FY20221.49B958.40M
FY20212.09B1.74B
FY20201.48B1.14B
FY20191.60B1.17B
FY20181.17B982.20M
FY20171.14B953.20M
FY20161.04B989.00M

Intuitive Surgical financial health

Full balance sheet
Cash and short-term investments
4.04B USD
Total debt
0.00 USD
Net cash
4.04B USD
Free cash flow (TTM)
3.60B USD
Current ratio
3.33
Debt to equity
0.00
Piotroski score
7 / 9
Altman Z-score
30.62

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20255.93B0.002.49B
FY20244.01B0.001.30B
FY20235.22B0.00749.60M
FY20224.12B0.00958.40M
FY20214.23B87.00M1.74B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY202520.46B2.52B17.82B
FY202418.74B2.21B16.43B
FY202315.44B2.04B13.31B
FY202212.97B1.86B11.04B
FY202113.56B1.60B11.95B
FY202011.17B1.41B9.76B
FY20199.73B1.45B8.28B
FY20187.85B1.16B6.68B
FY20175.76B1.03B4.73B
FY20166.49B709.10M5.78B

Intuitive Surgical valuation

Price to earnings ratio (TTM)
53.00
Forward P/E (FY2026)
39.40
Price to sales (TTM)
13.28
Price to book
9.62
EV / EBITDA (TTM)
35.73

Capital structure

Market capitalization
153.76B USD
+
Total debt
0.00 USD
−
Cash and short-term investments
4.04B USD
=
Enterprise value
149.72B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)31.61————
FY2027 (est.)35.5231.61———
FY2026 (est.)39.4035.52———
Now (TTM)53.0035.9813.289.6235.73
FY202570.8050.3220.0811.3449.83
FY202479.8160.1622.2011.2858.48
FY202365.8949.0216.638.9047.95
FY202271.3347.4315.178.5547.05
FY202175.0176.9322.4110.7157.60

Intuitive Surgical against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Becton, Dickinson and, Medline, ResMed, and West Pharmaceutical Services, the US Medical - Instruments & Supplies companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Below its median53.0
    37.596.4
  • Gross marginLowest in 5 years66.0%
    66.0%69.3%
    Against its peers: 1 of 5Peers' median 41.6%
  • Operating marginAbove its median29.3%
    24.8%31.9%
    Against its peers: 2 of 5Peers' median 15.8%
  • Net marginAbove its median28.4%
    21.3%29.9%
    Against its peers: 1 of 5Peers' median 11.0%
  • Return on equityHighest in 5 years16.0%
    12.0%16.0%
    Against its peers: 2 of 5Peers' median 13.2%
  • Free cash flow marginAbove its median24.7%
    10.5%30.4%
    Against its peers: 2 of 5Peers' median 14.5%
  • Revenue growthAbove its median20.5%
    9.0%31.0%
    Against its peers: 1 of 5Peers' median 8.1%
  • EPS growthBelow its median22.6%
    -21.7%58.5%
    Against its peers: 1 of 5Peers' median -2.1%
  • Debt to EBITDALowest in 5 years0.00×
    0.00×0.04×
    Against its peers: 1 of 5Peers' median 2.04×
  • Current ratioAbove its median4.87
    4.075.08
    Against its peers: 1 of 5Peers' median 3.06

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Intuitive Surgical ownership

Institutions
87.11%
Institutional holders
2,363 (-52)
Free float
99.41%

Who owns the shares

Institutions 87.1% Others 12.9%
As of 30 Jun 2026

Shares free to trade

Free float 344.61M shares ·99.4% Closely held 2.04M shares ·0.6%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 202601316.55K62.58K
Q3 20260193.00K16.00K
Q2 202601517.06K19.91K
Q1 2026020340.26K293.61K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025356.90M362.70M+0.19%
FY2024355.20M362.00M+1.29%
FY2023351.20M357.40M-1.27%
FY2022355.70M362.00M-1.04%
FY2021356.10M365.80M+1.36%

Common questions about Intuitive Surgical's financials

Source: Financial Modeling PrepVerified against SEC filings